Mary McNamara-Cullinane
Consigliere Generale presso CLEARPOINT NEURO, INC.
Posizioni attive di Mary McNamara-Cullinane
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| CLEARPOINT NEURO, INC. | Consigliere Generale | 08/08/2022 | - |
Storia della carriera di Mary McNamara-Cullinane
Precedenti posizioni note di Mary McNamara-Cullinane
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Molecular Biometrics, Inc.
 Molecular Biometrics, Inc. Miscellaneous Commercial ServicesCommercial Services Molecular Biometrics, Inc. used to develop analytical methodologies for molecular diagnostic. It developed highly specific and sensitive analytical methodologies for molecular diagnostic and monitoring applications in medicine, and for drug discovery and development through pharmacodiagnostics. The company was founded in 2005 and was headquartered in Norwood, MA. | Consigliere Generale | - | - |
| ECHO THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 19/12/2013 | - |
| Consigliere Generale | 19/12/2013 | - | |
| Corporate Officer/Principal | - | 19/12/2013 |
Formazione di Mary McNamara-Cullinane
| Massachusetts College of Liberal Arts | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
Posizioni
| General Counsel | 3 |
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CLEARPOINT NEURO, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Echo Therapeutics, Inc.
 Echo Therapeutics, Inc. Medical SpecialtiesHealth Technology Echo Therapeutics, Inc. is a medical device company, which engages in the development of non-invasive, and wireless continuous glucose monitoring system for use in the diabetes outpatient market. It offers needle-free skin preparation device as a platform technology that allows for enhanced skin permeation enabling extraction of analytes, such as glucose and delivery of topical pharmaceuticals. The company was founded in 1989 and is headquartered in Iselin, NJ. | Health Technology |
Molecular Biometrics, Inc.
Molecular Biometrics, Inc. Miscellaneous Commercial ServicesCommercial Services Molecular Biometrics, Inc. used to develop analytical methodologies for molecular diagnostic. It developed highly specific and sensitive analytical methodologies for molecular diagnostic and monitoring applications in medicine, and for drug discovery and development through pharmacodiagnostics. The company was founded in 2005 and was headquartered in Norwood, MA. | Commercial Services |
